Nobutatsu Takayanagi
- Hepatology top 10%
-
- Peptidase Inhibition and Analysis 3
-
- Liver Disease Diagnosis and Treatment 3
-
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 7
- Medical Imaging and Pathology Studies 5
-
- Cholangiocarcinoma and Gallbladder Cancer Studies 5
- Pediatric Hepatobiliary Diseases and Treatments 3
-
- Eosinophilic Disorders and Syndromes 3
-
- Chronic Lymphocytic Leukemia Research 2
- Co-authors
- Akitaka NonomuraGoroku OhtaYasuni NakanumaHisao MatsunouKishichiro WatanabeFumio KonishiNoboru YamamichiMakio Mukai
- Cited by
- HepatologyOncologyGastroenterology
- Partner nations
- JapanNetherlands
In The Last Decade
Nobutatsu Takayanagi
41 papers receiving 435 citations
Peers
Comparison fields: 5 of 48
- Hepatology 92
- Oncology 152
- Gastroenterology 30
- Epidemiology 134
- Pulmonary and Respiratory Medicine 119
Countries citing papers authored by Nobutatsu Takayanagi
This map shows the geographic impact of Nobutatsu Takayanagi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nobutatsu Takayanagi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nobutatsu Takayanagi more than expected).
Fields of papers citing papers by Nobutatsu Takayanagi
This network shows the impact of papers produced by Nobutatsu Takayanagi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nobutatsu Takayanagi. The network helps show where Nobutatsu Takayanagi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Nobutatsu Takayanagi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 8 | |
| 2 | [Familial summer-type hypersensitivity pneumonitis in a grandfather and his two-and-a-half-year-old grandson]. | 2000 | 4 |
| 3 | 1996 | 42 | |
| 4 | 1995 | 17 | |
| 5 | 1994 | 3 | |
| 6 | 1994 | 0 | |
| 7 | 1994 | 18 | |
| 8 | [Spontaneous regression of small cell lung cancer]. | 1994 | 7 |
| 9 | 1992 | 8 | |
| 10 | 1991 | 1 | |
| 11 | 1991 | 30 | |
| 12 | 1990 | 5 | |
| 13 | 1990 | 50 | |
| 14 | 1989 | 9 | |
| 15 | 1988 | 43 | |
| 16 | 1988 | 2 | |
| 17 | 1987 | 1 | |
| 18 | 1987 | 4 | |
| 19 | Immunohistochemical detection of ras oncogene p21 product in liver cirrhosis and hepatocellular carcinoma. | 1987 | 50 |
| 20 | Pathological study on livers with noncirrhotic portal hypertension and portal venous thromboembolic occlusion: report of seven autopsy cases. | 1984 | 14 |
About Nobutatsu Takayanagi
Nobutatsu Takayanagi is a scholar working on Hepatology, Oncology and Pulmonary and Respiratory Medicine, having authored 46 papers that have together received 454 indexed citations. Recurring topics across this work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (7 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers), Medical Imaging and Pathology Studies (5 papers), Pediatric Hepatobiliary Diseases and Treatments (3 papers), Peptidase Inhibition and Analysis (3 papers), Liver Disease Diagnosis and Treatment (3 papers), Eosinophilic Disorders and Syndromes (3 papers) and Chronic Lymphocytic Leukemia Research (2 papers). The work is most often cited by research in Hepatology (92 citations), Oncology (152 citations) and Gastroenterology (30 citations). Nobutatsu Takayanagi has collaborated with scholars based in Japan and Netherlands. Frequent co-authors include Akitaka Nonomura, Goroku Ohta, Yasuni Nakanuma, Hisao Matsunou, Kishichiro Watanabe, Fumio Konishi, Noboru Yamamichi, Makio Mukai, Yuji Mizukami and Ryohei Izumi. Their work appears in journals such as Cancer, Medicine and World Journal of Surgery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.